Mancini, M.; Thomas, Q.-D.; Bourdel, S.; Papon, L.; Bousquet, E.; Jalta, P.; La Monica, S.; Travert, C.; Alfieri, R.; Quantin, X.;
et al. Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance. Cancers 2021, 13, 3441.
https://doi.org/10.3390/cancers13143441
AMA Style
Mancini M, Thomas Q-D, Bourdel S, Papon L, Bousquet E, Jalta P, La Monica S, Travert C, Alfieri R, Quantin X,
et al. Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance. Cancers. 2021; 13(14):3441.
https://doi.org/10.3390/cancers13143441
Chicago/Turabian Style
Mancini, Maicol, Quentin-Dominique Thomas, Sylvia Bourdel, Laura Papon, Emilie Bousquet, Prisca Jalta, Silvia La Monica, Camille Travert, Roberta Alfieri, Xavier Quantin,
and et al. 2021. "Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance" Cancers 13, no. 14: 3441.
https://doi.org/10.3390/cancers13143441
APA Style
Mancini, M., Thomas, Q.-D., Bourdel, S., Papon, L., Bousquet, E., Jalta, P., La Monica, S., Travert, C., Alfieri, R., Quantin, X., Cañamero, M., & Maraver, A.
(2021). Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance. Cancers, 13(14), 3441.
https://doi.org/10.3390/cancers13143441
